AxoGen, Inc. (AXGN) was a big mover last session, as the company saw its shares rise over 25% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $3.35 to $3.64 since Dec 16.
This regenerative medicine company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in a trend either. Tuesday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
AxoGen currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the broader medical sector include Cepheid (CPHD), Achillion Pharmaceuticals, Inc. (ACHN) and Align Technology Inc. (ALGN). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AXOGEN INC (AXGN): Free Stock Analysis Report
CEPHEID INC (CPHD): Free Stock Analysis Report
ACHILLION PHARMACEUTICALS INC (ACHN): Free Stock Analysis Report
ALIGN TECHNOLOGY INC (ALGN): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies